QUICK TAKE: When to consider allergy referral, part 2: Rhinitis and rhinosinusitis
September 1st 2006This year, the American Academy of Allergy, Asthma, and Immunology (AAAAI) published guidelines for referring patients to an allergist/immunologist.1 The AAAAI's recommendations for patients with asthma were summarized in the July 2006 issue of
Clinical Citations: Antifungal therapy for pulmonary aspergillosis: The results of 2 studies
September 1st 2006Two recent studies provide encouraging data about the effectiveness of voriconazole in the treatment of aspergillosis. One study found that voriconazole was effective in the management of subacute invasive aspergillosis and chronic pulmonary aspergillosis. The other study found that it was beneficial in the treatment of chronic cavitary pulmonary aspergillosis.
Subclinical Hypothyroidism: REFERENCES: EvidencE-based medicine: Relevant guidelines:
September 1st 2006ABSTRACT: Subclinical hypothyroidism is associated with elevated low-density lipoprotein (LDL) cholesterol levels and several factors related to atherosclerosis, including increased C-reactive protein levels and impaired endothelium-dependent vasodilatation. However, considerable controversy exists about screening for and treating this thyroid disorder. Thyroxine therapy lowers elevated LDL cholesterol levels in patients whose serum thyroid-stimulating hormone (TSH) concentrations are higher than 10 mIU/L ; thus, most experts recommend treatment for such patients. However, there is no consensus regarding the management of patients with TSH levels of less than 10 mIU/L. Although the evidence supporting treatment of these patients is not compelling, it is reasonable to offer a therapeutic trial of thyroxine to those who have symptoms.
Barriers to Care in Chronic Disease: How to Bridge the Treatment Gap
September 1st 2006ABSTRACT: Our knowledge of chronic diseases has advanced significantly in recent decades, but patient outcomes have not kept pace. This is largely because the traditional acute care model does not adequately address the needs of patients with chronic disease. Patients play an active role in the management of chronic disease, and successful outcomes are highly dependent on adherence to treatment. Thus, clinicians need to have skills in coaching and encouraging as well as an awareness of factors in patients' backgrounds that are likely to affect their ability or willingness to follow treatment plans. Provider- and system-related factors, such as lack of reimbursement for counseling and high copayments, can also act as barriers to compliance. Among the strategies that can improve adherence are the use of community resources, multidisciplinary approaches, and regular follow-up.
OTC Statins: The Debate Continues
September 1st 2006The recent editorial by David T. Nash, MD, "OTC Statins: Panacea or Pandora's Box?" (CONSULTANT, July 2006, page 845), prompted a number of readers to write in. A selection of the comments received, along with a response from Dr Nash, appears below. Additional comments appear on www.ConsultantLive.com.
Leukocytoclastic Vasculitis: A Marker of Underlying Malignancy
September 1st 2006A 62-year-old man presents with a violaceous, nonpruritic eruption that arose 2 weeks earlier on the hands and feet, including the palms and soles, and spread to the arms and legs (Figure 1). Over the past 3 to 4 weeks, he has had malaise, nonproductive cough, and a decline in mental status but no fever, headache, nausea, light-headedness, hemoptysis, or melena.
Treating Eye Irritation in a Child: An Office Tip
September 1st 2006When young children have an irritant in their eyes, it can be very difficult to get them to open their eyes so that they can be irrigated. To reduce the stinging and make opening the eyes easier, try putting a drop of an ocular anesthetic in each medial canthus while the child is supine; be sure to wait for it to seep in.- D. Brady Pregerson, MD Los AngelesMore Practical Pointers
Prehypertension: To Treat or Not To Treat?
September 1st 2006The term "prehypertension" was introduced in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines to describe blood pressures (BPs) of 120/80 mm Hg to 139/89 mm Hg.1